Filter
5708
Filtered Results: 5708
Text search:
burden
of
disease
Featured
Recommendations
463
New Publications
1380
Language
Document type
No document type
3004
Studies & Reports
1291
Guidelines
624
Strategic & Response Plan
253
Manuals
233
Fact sheets
138
Training Material
69
Situation Updates
28
Infographics
25
Resource Platforms
23
Brochures
7
Dashboards/Maps
5
Online Courses
5
Videos
3
Countries / Regions
Global
361
India
259
Kenya
178
Western and Central Europe
143
South Africa
138
Ethiopia
117
Africa
110
Latin America and the Carribbean
103
Uganda
97
Nigeria
94
Sierra Leone
90
Liberia
85
Tanzania
81
Nepal
78
Malawi
78
Zambia
72
Bangladesh
68
Ghana
67
Rwanda
61
Ukraine
61
Eastern Europe
60
Namibia
54
Myanmar / Burma
53
Syria
49
South–East Asia Region
49
Asia
49
Philippines
41
Mozambique
39
Zimbabwe
34
East and Southern Africa
34
Cambodia
33
Congo, Democratic Republic of
32
Russia
32
South Sudan
31
Lesotho
31
Indonesia
30
West and Central Africa
29
Brazil
28
Guinea
23
Botswana
23
Eastern Europe and Central Asia
22
Senegal
20
Germany
20
Middle East and North Africa
20
Pakistan
19
Eswatini/ Swaziland
17
Haiti
16
Burkina Faso
15
Sudan
15
Cameroon
14
Yemen
14
North America
14
Colombia
13
Western Pacific Region
13
USA
12
Venezuela
12
Afghanistan
11
Somalia
10
Thailand
10
Vietnam
10
Jordan
8
Benin
8
Central African Republic
8
Albania
8
Tajikistan
8
Iraq
7
Argentina
7
Peru
7
Chile
7
Moldova
7
Mali
6
Lebanon
6
Ecuador
6
Madagascar
6
Sri Lanka
6
Southern Africa
6
Laos
6
Georgia
6
North Macedonia
5
Mexico
5
Paraguay
5
Palestine
5
Iran
5
Jamaica
5
Saudi Arabia
4
Turkey
4
Egypt
4
China
4
Burundi
4
Libya
4
Angola
4
Armenia
4
Timor Leste/ East Timor
4
Greece
3
Poland
3
Romania
3
Kyrgyzstan
3
Turkmenistan
3
Mauritius
3
United Kingdom
3
Belarus
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Switzerland
2
Other region
2
Bhutan
2
Djibouti
2
Qatar
2
Kazakhstan
2
Gabon
2
Tunisia
2
Bosnia and Herzegovina
2
Morocco
1
Niger
1
Togo
1
Chad
1
Gambia
1
Ireland
1
Hungary
1
Honduras
1
El Salvador
1
Bolivia
1
Guatemala
1
North Korea
1
Mongolia
1
Canada
1
Bulgaria
1
Estonia
1
Slovakia
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Morocco
1
Azerbaijan
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
2043
Clinical Guidelines
531
Public Health
498
Women & Child Health
209
Key Resources
173
Capacity Building
66
Pharmacy & Technologies
37
Annual Report MEDBOX
2
Toolboxes
TB
503
HIV
484
Mental Health
460
COVID-19
414
NCDs
295
Planetary Health
265
AMR
217
NTDs
213
Disability
141
Global Health Education
133
Caregiver
130
Rapid Response
119
Conflict
111
Ebola
80
Health Financing Toolbox
76
Refugee
71
Pharmacy
58
Natural Hazards
41
Polio
29
Cholera
28
Zika
18
Social Ethics
18
Specific Hazards
15
South Sudan
1
Health Financing
1
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery ... (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor for developing chronic kidney disease (CKD), which in itself is associated with developing CVD. The combination of diabetes with these cardio-renal comorbidities enhances the risk not only for cardiovascular (CV) events but also for CV and all-cause mortality. The current European Society of Cardiology (ESC) Guidelines on the management of cardiovascular disease in patients with diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes based on data published until end of January 2023. Over the last decade, the results of various large cardiovascular outcome trials (CVOTs) in patients with diabetes at high CV risk with novel glucose- lowering agents, such as sodium–glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), but also novel non-steroidal mineralocorticoid receptor antagonists (MRAs), such as finerenone have substantially expanded available therapeutic op-
tions, leading to numerous evidence-based recommendations for the management of this patient population.
The Road to Recovery. This synthesis report is based on three national studies on the evolution of the Ebola epidemic and its impact on Guinea, Liberia and Sierra Leone
Ghana Med J. 2012 Jun;46(2 Suppl):69-78.
The document covers: introduction on contact tracing in the Ebola response; general considerations for contact tracing; case definition; planning and preparation; personnel; implementation, and tools for contact tracing.
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascula...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via co...
Accessed on 07.03.2023
A – Z of Rabies – A guide to the world´s deadliest disease
Mission Rabies
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life...
The Water, Sanitation, and Hygiene Improvement Training Package is intended to support the training of local outreach workers and their subsequent work in communities to promote improved water, sanitation and hygiene (WASH) practices to reduce diarr...
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV .... Current clinical guidelines and policies regarding optimal packages of care for high-risk patients give few or no recommendations about how, by whom, or where they should be delivered for optimal impact.
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients unde...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent ... a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline development (5). A multidisciplinary development group was formed, comprised of thematic experts, epidemiologists, methodologists, and users. Since there were no existing guidelines that could be adapted, the guidelines were developed from scratch.
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmi...
